1. Home
  2. CLWT vs APRE Comparison

CLWT vs APRE Comparison

Compare CLWT & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

N/A

Current Price

$1.17

Market Cap

9.2M

ML Signal

N/A

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.71

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLWT
APRE
Founded
1971
2006
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.4M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CLWT
APRE
Price
$1.17
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
6.8K
76.8K
Earning Date
04-29-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.22
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.55
52 Week High
$1.63
$2.30

Technical Indicators

Market Signals
Indicator
CLWT
APRE
Relative Strength Index (RSI) 49.07 41.99
Support Level $1.20 $0.55
Resistance Level $1.30 $0.95
Average True Range (ATR) 0.05 0.06
MACD -0.01 -0.01
Stochastic Oscillator 38.46 17.41

Price Performance

Historical Comparison
CLWT
APRE

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Share on Social Networks: